A

Alkermes plc
D

ALKS

30.070
USD
-0.68
(-2.21%)
مغلق
حجم التداول
53,674
الربح لكل سهم
2
العائد الربحي
-
P/E
13
حجم السوق
4,865,401,416
أصول ذات صلة
    A
    AAL
    -0.250
    (-1.50%)
    16.470 USD
    A
    ALGT
    -2.790
    (-3.33%)
    80.990 USD
    A
    ALK
    -0.720
    (-1.14%)
    62.470 USD
    DAL
    DAL
    -1.920
    (-3.16%)
    58.880 USD
    H
    HA
    0.690
    (3.99%)
    18.000 USD
    J
    JBLU
    -0.30500
    (-4.17%)
    7.00500 USD
    L
    LUV
    -0.360
    (-1.10%)
    32.450 USD
    S
    SAVE
    -0.24000
    (-18.18%)
    1.08000 USD
    U
    UAL
    -3.530
    (-3.72%)
    91.450 USD
    المزيد
الأخبار

العنوان: Alkermes plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.